KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Acquisitions & Divestments (2016 - 2026)

Aurinia Pharmaceuticals filings provide 7 years of Change in Acquisitions & Divestments readings, the most recent being $145.3 million for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 17.25% to $145.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $494.1 million, a 15.59% decrease, with the full-year FY2025 number at $494.1 million, down 15.59% from a year prior.
  • Change in Acquisitions & Divestments hit $145.3 million in Q4 2025 for Aurinia Pharmaceuticals, up from $93.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $170.5 million in Q1 2024 to a low of $60.9 million in Q1 2021.
  • Median Change in Acquisitions & Divestments over the past 5 years was $120.5 million (2023), compared with a mean of $122.3 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 81.43% in 2022 and later fell 29.47% in 2025.
  • Aurinia Pharmaceuticals' Change in Acquisitions & Divestments stood at $90.7 million in 2021, then surged by 30.36% to $118.2 million in 2022, then increased by 16.82% to $138.1 million in 2023, then fell by 10.22% to $124.0 million in 2024, then grew by 17.25% to $145.3 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $145.3 million (Q4 2025), $93.5 million (Q3 2025), and $132.2 million (Q2 2025) per Business Quant data.